Studies on the mode of action of the copper(II)chelate of 2-keto-3-ethoxybutyraldehyde-bis(thiosemicarbazone).
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002247:Carbon Isotopes; D002279:Carcinoma 256, Walker / Q000378:metabolism; D002614:Chelating Agents / Q000494:pharmacology*; D003300:Copper / Q000494:pharmacology; D046508:Culture Techniques; D004247:DNA / Q000096:biosynthesis*; D004261:DNA Replication / Q000187:drug effects*; D004273:DNA, Neoplasm / Q000096:biosynthesis; D009374:Neoplasms, Experimental / Q000378:metabolism; D009705:Nucleosides / Q000378:metabolism; D010770:Phosphotransferases / Q000037:antagonists & inhibitors*; D014176:Protein Biosynthesis; D012313:RNA / Q000096:biosynthesis*; D012334:RNA, Neoplasm / Q000096:biosynthesis; D051381:Rats; D013882:Thiosemicarbazones / Q000494:pharmacology*; D013936:Thymidine / Q000378:metabolism; D013937:Thymidine Kinase / Q000037:antagonists & inhibitors; D014316:Tritium; D014529:Uridine / Q000378:metabolism; D014633:Valine / Q000378:metabolism; D015032:Zinc / Q000494:pharmacology
D000970:Antineoplastic Agents; D002247:Carbon Isotopes; D002614:Chelating Agents; D004273:DNA, Neoplasm; D009705:Nucleosides; D012334:RNA, Neoplasm; D013882:Thiosemicarbazones; D014316:Tritium; D012313:RNA; D003300:Copper; D004247:DNA; D010770:Phosphotransferases; D013937:Thymidine Kinase; D014633:Valine; D015032:Zinc; D013936:Thymidine; D014529:Uridine